Velatir
Velatir provides an AI governance platform that helps organizations monitor, manage, and control the use of AI across workplace tools.
Velatir provides an AI governance platform that helps organizations monitor, manage, and control the use of AI across workplace tools.
Velatir has raised $5.8M across 1 round. Its most recent round was a Seed of $5.8M in Aug 2026. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles, verified email addresses and LinkedIn profiles.
Velatir is featured in
Similar companies
Pre-assessments done. More time for care. Aisel’s AI conducts pre-assessments and delivers structured reports that fit directly into psychiatric workflows - saving clinics up to 30 minutes per consultation. Designed to feel like your most reliable colleague, Aisel enhances efficiency without compromising human care.
Palette is a model-agnostic operating system designed for AI-native teams to work collaboratively with AI agents.
Visibuilt is to pioneer sustainable road-building solutions by replacing standard asphalt with cutting-edge, environmentally materials.
The Hub is a recruitment platform for Nordic startups that offers career opportunities for global talents.
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several cancer indications. The Company has developed a highly specific PET (Positron emission tomography) imaging ligand, uTRACE®, targeting the receptor uPAR, which is a biomarker only expressed in cancer. uTRACE® will become a game-changer in the diagnosis and treatment of cancer patients. In addition, with the promising results obtained within diagnostics Curasight will also pursues uPAR targeted radionuclide therapy using the uTREAT® ligand. As PET imaging and radionuclide therapy is based on the same uPAR binding peptide, a uTRACE® scan can precisely predict where subsequent targeted radiation therapy will be delivered. uTRACE® covers the diagnostic path and uTREAT® covers the therapy. This will be the new management and treatment of cancer patients in the future.
Acodyne is made for delivering cargo in difficult-to-reach locations for both military and commercial uses. Middle-mile logistics is being revolutionized globally by Acodyne's creation of the quickest unmanned eVTOL aircraft for large payloads.
TechBBQ is a non-profit event management organization that hosts startup capital programs.
Kvasir Technologies is a firm that has created a game-changing method to manufacture environmentally acceptable fuel for difficult-to-abate industries.
Franklin Technologies is a fintech company that provides e-commerce finance, payment cards, and automated accounting solutions.
Festina Lente is a company that specializes in providing knowledge-based solutions. Our focus is on developing advisory systems that provide individuals with a comprehensive understanding of their finances.
Trophy Games is a studio that develops a wide range of mobile and online games.
Returnflows is a SaaS tool that helps Shopify-based webshops convert up to 50% of return volume into gift cards and exchanges.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.